Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Suralis vibrotactile system for phantom limb pain after lower-limb amputation

Official title: Clinical Application Observation: Evaluation of Phantom Limb Pain After 3 Weeks of Use of a Feedback System Using Vibration (Suralis, Manufacturer: Saphenus)

Run by Median · NCT07324109 · Data updated 2026-11-12

This pilot will test whether wearing the Suralis vibration feedback system during walking reduces phantom limb pain in people with a unilateral lower-limb amputation.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorMedian
Academic / other
Locations1 site (Wiesbaden, Hesse)
StatusRecruiting
StartedApril 1, 2025
Main results expectedJuly 31, 2026
Study endsJuly 31, 2026
Registry record updatedJanuary 7, 2026
Trial IDNCT07324109 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with a unilateral major lower-limb amputation who have persistent daily phantom limb pain (VAS ≥ 3/10), use a prosthesis at least 4 hours per day, speak German, and can give informed consent.

Probably not a fit

People with unstable residual limb wounds, inconsistent or insufficient prosthesis use, poor-fitting prostheses, or who cannot complete German-language assessments are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-arm pilot where participants complete a 3-week baseline, 3 weeks of using the Suralis vibrotactile feedback system during daily ambulation, and a 3-week washout follow-up. The Suralis system uses a sensorized insole to detect pressure and activates thigh-mounted vibrotactile actuators with individually calibrated intensity and timing. Outcomes include daily VAS pain scores, gait tests (TUG, 6MWT), and validated questionnaires of function and quality of life collected at the study center. The device is CE-marked (Class IIa) and has been used without reported device-related adverse events in prior clinical use.

Why it matters

Potential benefit: If successful, the Suralis system could provide a non-drug, wearable option to reduce phantom limb pain and improve walking function and quality of life for amputees.

How similar studies have gone: Small studies and case reports of vibrotactile sensory feedback or sensory substitution have shown promising pain or function signals, but larger controlled trials are still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Unilateral major lower-limb amputation (transtibial or transfemoral)
* Presence of persistent phantom limb pain, defined as daily pain intensity ≥ 3/10 on the Visual Analog Scale (VAS) during the baseline period
* Regular daily use of a prosthetic limb (minimum 4 hours/day)
* Adequate German language proficiency to understand and complete study questionnaires and follow study procedures
* Ability to provide informed consent

Exclusion Criteria:

* Unstable wound or skin condition at the residual limb
* Inconsistent prosthetic use (less than daily or \< 4 hours/day)
* Poorly fitting or non-functional prosthesis (as determined by study team)
* Incapacity to provide informed consent (e.g., due to cognitive impairment or severe psychiatric illness)
* Insufficient German language skills to comprehend study materials or complete assessments reliably

Where it's running

  • MEDIAN Rehab Center Wiesbaden Sonnenberg
    Wiesbaden, Hesse, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.